CHANGE IN RATINGS
was upgraded at Deutsche from Hold to Buy. Valuation call, as the stock is likely to soon reach a bottom. $52 price target.
upgraded at Jefferies to Buy rating from Hold. Price target and FY 2008 EPS estimates hold at $6.50 and $0.25, respectively.
upgraded at JP Morgan from Neutral to Overweight. Company has cut its debt load, and now has the flexibility to pursue new strategies. In the meantime, the stock trades at a 10% discount to its peers.
upgraded at Credit Suisse to Outperform from Neutral. Cites increasingly attractive risk/reward balance. Maintained $39 target price.
upgraded at Deutsche Bank to Buy rating from Hold. Price target holds at $56 while FY 2008 EPS estimates bump up to $3.58 from $3.57.
( LNCR) downgraded at Oppenheimer from Buy to Neutral. Stock has risen lately, but the risk for lower Medicare oxygen payments remains.
( MDTH) rated new Neutral at Credit Suisse. Sees sustained EPS growth from organic operations but shares appeared fairly valued. Sets $25 target price.
upgraded at Bear from Underperform to Peer Perform. Valuation call, as the sum of the company's parts is near the current price.
downgraded at JP Morgan from Neutral to Underweight. Valuation call, as the stock trades at a 44% premium to EQ.
STOCK COMMENTS / EPS CHANGES
estimates lowered at Goldman to $1.90 from $2.23 due the poorer-than-expected results of Bee Movie and weakness in DVD market. See negatives as fully priced-in and believe current quote is buying opportunity. Price target cut to $34 from $37 and reiterated Buy rating.
2008 estimates cut at Credit Suisse to 19 cents from 34 cents based on lower natural gas prices, less of an impact from LS Power and a modestly lower tax rate. Reduced target price to $8.50 from $10.
( NCC) numbers lowered at UBS. Price target slashed to $17 from $22 and FY 2008 EPS estimates cut to $1.10 from $1.72. Reiterates Neutral rating.
price target raised at Goldman to $73 from $64 based on expected strong Q2 results. Note strong international demand and foreign exchange benefits. Maintained Buy rating.
target price raised at Credit Suisse to $98 from $80. Believes market fears regarding AWP's are overdone, strength overseas will continue and margins will hold-up next year as product mix improves. Maintained Outperform rating.
( VTIV) numbers lowered at Jefferies. Price target dips to $41 from $44 and FY 2008 EPS estimates drop to $1.88 from $1.90. Reiterates Buy rating.